Impact of body mass index on growth hormone stimulation tests in children and adolescents: a systematic review and meta-analysis

References

• World Health Organization (WHO). Obesity and overweight fact sheet. 2020 [cited 2020 Jan 8]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight
   Google Scholar
• Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(3):709–757.
   PubMed Web of Science ®Google Scholar
• Collett-Solberg PF, Ambler G, Backeljauw PF, et al. Diagnosis, genetics, and therapy of short stature in children: a growth hormone research society international perspective. Horm Res Paediatr. 2019;92(1):1–14.
   PubMed Web of Science ®Google Scholar
• Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-i deficiency. Horm Res Paediatr. 2016;86(6):361–397.
   PubMed Web of Science ®Google Scholar
• Low MJ. Neuroendocrinology (Chapter 7). In: Melmed S, Polonsky KS, Larsen PR, eds. Williams textbook of endocrinology. 12th ed. Philadelphia (PA): W.B. Saunders; 2011. p. 103–174.
   Google Scholar
• Baron J, Sävendahl L, De Luca F, et al. Short and tall stature: a new paradigm emerges. Nat Rev Endocrinol. 2015;11(12):735–746.
   PubMed Web of Science ®Google Scholar
• Kreitschmann-Andermahr I, Suarez P, Jennings R, et al. GH/IGF-I regulation in obesity-mechanisms and practical consequences in children and adults. Horm Res Paediatr. 2010;73(3):153–160.
   PubMed Web of Science ®Google Scholar
• Mazzanti L, Tamburrino F, Bergamaschi R, et al. Developmental syndromes: growth hormone deficiency and treatment. Endocr Dev. 2009;14:114–134.
   PubMedGoogle Scholar
• Dichtel LE, Yuen KC, Bredella MA, et al. Overweight/obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency. J Clin Endocrinol Metab. 2014;99(12):4712–4719.
   PubMed Web of Science ®Google Scholar
• Corneli G, Di Somma C, Baldelli R, et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur j Endocrinol. 2005;153(2):257–264.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. J Am Med Assoc. 2000;283(15):2008–2012.
   PubMed Web of Science ®Google Scholar
• Bramer WM. Reference checking for systematic reviews using endnote. J Med Libr Assoc. 2018;106(4):542–546.
   PubMed Web of Science ®Google Scholar
• Phillips S, Edlbeck A, Kirby M, et al. Ideal body weight in children. Nutr Clin Pract. 2007;22(2):240–245.
   PubMed Web of Science ®Google Scholar
• Smith DW. Growth and its disorders: basics and standards, approach and classifications, growth deficiency disorders, growth excess disorders, obesity. Major Probl Clin Pediatr. 1977;15:1–155.
   PubMedGoogle Scholar
• Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000;8(314):1–27.
   Google Scholar
• World Health Organization (WHO). WHO child growth standards. World Health Organization; 2006 [cited 2020 Oct 22]. Available from: https://www.who.int/childgrowth/publications/technical_report_pub/en/
   Google Scholar
• Scottish Intercollegiate Guidelines Network. SIGN methodology checklists Edinburgh. [cited 2020 Oct 22]. Available from: https://www.sign.ac.uk/what-we-do/methodology/checklists/
   Google Scholar
• Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions version 6.1 Cochrane; 2020 [cited 2020 Oct 22]. Available from: www.training.cochrane.org/handbook
   Google Scholar
• Borenstein M, Hedges LV, Higgins JPT, et al. Converting among effect sizes. Chapter 7. In: Introduction to meta-analysis. Chichester: John Wiley & Sons; 2009. p. 45–49.
   Google Scholar
• Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010. DOI:https://doi.org/10.18637/jss.v036.i03.
   Google Scholar
• Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046–1055.
   PubMed Web of Science ®Google Scholar
• Barrett J, Maranda L, Nwosu BU. The relationship between subnormal peak-stimulated growth hormone levels and auxological characteristics in obese children. Front Endocrinol. 2014 2014;5:35.
   PubMed Web of Science ®Google Scholar
• Beccaria L, Benzi F, Sanzari A, et al. Impairment of growth hormone responsiveness to growth hormone releasing hormone and pyridostigmine in patients affected by Prader-Labhardt-Willi syndrome. J Endocrinol Invest. 1996;19(10):687–692.
   PubMed Web of Science ®Google Scholar
• Bideci A, Cinaz P, Hasanoglu A, et al. Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in obese children. J Pediatr Endocrinol Metab. 1997;10(3):295–299.
   PubMed Web of Science ®Google Scholar
• Cappa M, Grossi A, Borrelli P, et al. Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome. Horm Res. 1993;39(1–2):51–55.
   PubMedGoogle Scholar
• Carnelutti M, Del Guercio MJ, Chiumello G. Influence of growth hormone on the pathogenesis of obesity in children. J Pediatr. 1970;77(2):285–293.
   PubMed Web of Science ®Google Scholar
• Cavallo L, Gurrado R, Bernasconi S, et al. Endogenous growth hormone secretion does not correlate with growth in patients with Turner's syndrome. J Pediatr Endocrinol Metab. 1999;12(5):623–627.
   PubMed Web of Science ®Google Scholar
• Cordido F, Casanueva FF, Dieguez C. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity. J Clin Endocrinol Metab. 1989;68(2):290–293.
   PubMed Web of Science ®Google Scholar
• Cordido F, Dieguez C, Casanueva FF. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects. J Clin Endocrinol Metab. 1990;70(5):1361–1370.
   PubMed Web of Science ®Google Scholar
• Costeff H, Holm VA, Ruvalcaba R, et al. Growth hormone secretion in Prader-Willi syndrome. Acta Paediatr Scand. 1990;79(11):1059–1062.
   PubMed Web of Science ®Google Scholar
• Coutant R, Lahlou N, Bouvattier C, et al. Circulating leptin level and growth hormone response to stimulation tests in obese and normal children. Eur J Endocrinol. 1998;139(6):591–597.
   PubMed Web of Science ®Google Scholar
• Croughs W, Schopman W, Tiddens HAWM. Plasma growth hormone response to insulin induced hypoglycemia. Helv Paediatr Acta. 1968;23(5):464–477.
   PubMedGoogle Scholar
• de Sanctis L, Bellone J, Salerno M, et al. GH secretion in a cohort of children with pseudohypoparathyroidism type Ia. J Endocrinol Invest. 2007;30(2):97–103.
   PubMed Web of Science ®Google Scholar
• Germain-Lee EL, Groman J, Crane JL, et al. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab. 2003;88(9):4059–4069.
   PubMed Web of Science ®Google Scholar
• Ghigo E, Mazza E, Corrias A, et al. Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children. Metabolism. 1989;38(7):631–633.
   PubMed Web of Science ®Google Scholar
• Girard J, Stahl M, Nars PW, et al. Endocrine disturbances in childhood obesity: growth-hormone and cortisol response to insulin induced hypoglycemia. Klin Wochenschr. 1972;50(14):706–710.
   PubMedGoogle Scholar
• Josefsberg Z, Kauli R, Keret K. Growth hormone response to insulin tolerance test and arginine stimulation in obese children and adolescents. Pediatr Adolesc Endocrinol. 1976;1:146–152.
   Google Scholar
• Kaplan SL, Abrams CA, Bell JJ, et al. Growth and growth hormone. I. Changes in serum level of growth hormone following hypoglycemia in 134 children with growth retardation. Pediatr Res. 1968;2(1):43–63.
   PubMed Web of Science ®Google Scholar
• Komatsu F. Growth hormone secretion in children. Part II: The responses of growth hormone secretion with insulin induced hypoglycemia in various diseases. Pediatr Int. 1973;15(1):39–50.
   Google Scholar
• Lee HS, Hwang JS. Influence of Body Mass index on growth hormone responses to classic provocative tests in children with short stature. Neuroendocrinology. 2011;93(4):259–264.
   PubMed Web of Science ®Google Scholar
• Lee J, Yoon J, Kang MJ, et al. Influence of body mass index on the growth hormone response to provocative testing in short children without growth hormone deficiency. J Korean Med Sci. 2013;28(9):1351–1355.
   PubMed Web of Science ®Google Scholar
• Liang S, Zhang D, Qi J, et al. Reduced peak stimulated growth hormone is associated with hyperuricemia in obese children and adolescents. Sci Rep. 2018;8(1):7931.
   PubMedGoogle Scholar
• Loche S, Balzano S, Bozzola M, et al. Secretion of growth hormone releasing hormone in obese children. J Endocrinol Invest. 1992;15(6):453–457.
   PubMed Web of Science ®Google Scholar
• Loche S, Cambiaso P, Carta D, et al. The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects. J Clin Endocrinol Metab. 1995;80(2):674–678.
   PubMed Web of Science ®Google Scholar
• Loche S, Cappa M, Borrelli P, et al. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition. Clin Endocrinol. 1987;27(2):145–153.
   PubMed Web of Science ®Google Scholar
• Loche S, Cappa M, Faedda A, et al. The effect of pirenzepine on the growth hormone response to growth hormone-releasing hormone in obese children. Acta Medica Auxologica. 1993;25(3):163–167.
   Google Scholar
• Loche S, Guzzetti C, Pilia S, et al. Effect of body mass index on the growth hormone response to clonidine stimulation testing in children with short stature. Clin Endocrinol. 2011;74(6):726–731.
   PubMed Web of Science ®Google Scholar
• Loche S, Pintor C, Cappa M, et al. Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children. Acta Endocrinol. 1989 May;120(5):624–628.
   PubMedGoogle Scholar
• Loche S, Pintus S, Carta D, et al. The effect of atenolol on the growth hormone response to growth hormone-releasing hormone in obese children. Acta Endocrinol. 1992;126(2):124–127.
   PubMedGoogle Scholar
• Loche S, Pintus S, Cella SG, et al. The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese children. Clin Endocrinol. 1990;33(2):187–192. Aug
   PubMed Web of Science ®Google Scholar
• Martul P, Pineda J, Pombo M, et al. New diagnostic tests of GH reserve. J Pediatr Endocrinol. 1993;6(3–4):317–323.
   PubMedGoogle Scholar
• Misra M, Bredella MA, Tsai P, et al. Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab. 2008;295(2):E385–E392.
   PubMed Web of Science ®Google Scholar
• Parra A, Schultz RB, Graystone JE, et al. Correlative studies in obese children and adolescents concerning body composition and plasma insulin and growth hormone levels. Pediatr Res. 1971;5(11):605–613.
   Web of Science ®Google Scholar
• Pasquino AM, Bernardini S, Cianfarani S, et al. GH assessment and three years' hGH therapy in girls with Turner syndrome. Horm Res. 1992;38(3–4):120–124.
   PubMedGoogle Scholar
• Patel L, Skinner AM, Price DA, et al. The influence of body mass index on growth hormone secretion in normal and short statured children. Growth Regul. 1994;4(1):29–34.
   PubMedGoogle Scholar
• Perotti M, Perra S, Saluzzi A, et al. Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period. Horm Metab Res. 2013;45(10):748–753.
   PubMed Web of Science ®Google Scholar
• Pertzelan A, Keret R, Bauman B, et al. Responsiveness of pituitary hGH to GRH1-44 in juveniles with obesity. Acta Endocrinol. 1986;111(2):151–153. Feb
   PubMedGoogle Scholar
• Pintor C, Loche S, Puggioni R, et al. Growth hormone response to hpGRF-40 in different forms of growth retardation and endocrine-metabolic diseases. Eur J Pediatr. 1986;144(5):475–481.
   PubMed Web of Science ®Google Scholar
• Pirazzoli P, Mazzanti L, Bergamaschi R, et al. Reduced spontaneous growth hormone secretion in patients with Turner's syndrome. Acta Paediatr. 2007;88(6):610–613. Jun
   Google Scholar
• Ranke MB, Gruhler M, Rosskamp R, et al. Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency. Eur J Pediatr. 1986;145(6):485–492.
   PubMed Web of Science ®Google Scholar
• Reiter JC, Craen M, Van Vliet G. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: Relation to body weight and adiposity. Acta Endocrinol. 1991;125(1):38–42.
   PubMedGoogle Scholar
• Rosskamp R, Becker M, Soetadji S. Circulating somatomedin-C levels and the effect of growth hormone-releasing factor on plasma levels of growth hormone and somatostatin-like immunoreactivity in obese children. Eur J Pediatr. 1987;146(1):48–50.
   PubMed Web of Science ®Google Scholar
• Singh SK, Agrawal JK, Rai M, et al. Growth hormone response to clonidine in obese children. Indian Pediatr. 1991;28(7):737–740.
   PubMedGoogle Scholar
• Soliman AT, Rajab A, AlSalmi I, et al. Empty sellae, impaired testosterone secretion, and defective hypothalamic-pituitary growth and gonadal axes in children with Bardet-Biedl syndrome. Metabolism. 1996;45(10):1230–1234.
   PubMed Web of Science ®Google Scholar
• Stanley TL, Levitsky LL, Grinspoon SK, et al. Effect of body mass index on peak growth hormone response to provocative testing in children with short stature. J Clin Endocrinol Metab. 2009;94(12):4875–4881.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Inoue S, Shiraki J, et al. Age-related decrease in plasma growth hormone: Response to growth hormone-releasing hormone, arginine, and L-dopa in obesity. Metabolism. 1991;40(12):1257–1262.
   PubMed Web of Science ®Google Scholar
• Tanaka T. Growth hormone secretion and the therapeutic effects of human growth hormone: first Japanese results of the Kabi Pharmacia International Growth Study/International Cooperative Growth Study. Acta Paediatr Scand Suppl. 1991;379:126–135.
   PubMedGoogle Scholar
• Thacker MJ, Hainline B, St Dennis-Feezle L, et al. Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency. Horm Res. 1998;49(5):216–220.
   PubMedGoogle Scholar
• Topper E, Gil-Ad I, Bauman B, et al. Plasma growth hormone response to oral clonidine as compared to insulin hypoglycemia in obese children and adolescents. Horm Metab Res. 2008;16(S1):127–130.
   Google Scholar
• Vaccaro F, Cianfarani S, Pasquino AM, et al. Is obesity-related insulin status the cause of blunted growth hormone secretion in Turner's syndrome? Metabolism. 1995;44(8):1033–1037.
   PubMed Web of Science ®Google Scholar
• Van Vliet G, Bosson D, Rummens E, et al. Evidence against growth hormone-releasing factor deficiency in children with idiopathic obesity. Acta Endocrinol Suppl. 1986;279:403–410.
   PubMedGoogle Scholar
• Vanderschueren-Lodeweyckx M, Wolter R, Malvaux P, et al. The glucagon stimulation test: effect of plasma growth hormone and on immunoreactive insulin, cortisol, and glucose in children. J Pediatr. 1974;85(2):182–187.
   PubMed Web of Science ®Google Scholar
• Volta C, Bernasconi S, Iughetti L, et al. Growth hormone response to growth hormone-releasing hormone (GHRH), insulin, clonidine and arginine after GHRH pretreatment in obese children: evidence of somatostatin increase? Eur J Endocrinol. 1995;132(6):716–721.
   PubMed Web of Science ®Google Scholar
• Weber B, Helge H, Quabbe H-J. Glucagon-induced growth hormone release in children. Acta Endocrinol. 1970;65(2):323–341.
   PubMedGoogle Scholar
• Wegienka LC, Grodsky GM, Karam JH, et al. Comparison of insulin and 2-deoxy-D-glucose-induced glucopenia as stimulators of growth hormone secretion. Metabolism. 1967;16(3):245–256.
   PubMed Web of Science ®Google Scholar
• Yang A, Cho SY, Kwak MJ, et al. Impact of BMI on peak growth hormone responses to provocative tests and therapeutic outcome in children with growth hormone deficiency. Sci Rep. 2019;9(1):16181.
   PubMedGoogle Scholar
• Yau M, Chacko E, Regelmann MO, et al. Peak growth hormone response to combined stimulation test in 315 children and correlations with metabolic parameters. Horm Res Paediatr. 2019;92(1):36–44.
   PubMed Web of Science ®Google Scholar
• Casamitjana L, Giménez-Palop O, Corripio R, et al. Glucagon stimulation test to assess growth hormone status in Prader-Willi syndrome. J Endocrinol Invest. 2021;44(3):621–629.
   PubMed Web of Science ®Google Scholar
• Schott DA, Gerver WJ, Stumpel CT. growth hormone stimulation tests in children with Kabuki syndrome. Horm Res Paediatr. 2016;86(5):319–324.
   PubMed Web of Science ®Google Scholar
• Roth J, Glick SM, Yalow RS, et al. Hypoglycemia: a potent stimulus to secretion of growth hormone. Science. 1963;140(3570):987–988.
   PubMedGoogle Scholar
• May J. Obesity and plasma levels of insulin and growth hormone. Nutr Rev. 1965;23:102–104.
   PubMedGoogle Scholar
• Veldhuis JD, Iranmanesh A, Ho KK, et al. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab. 1991;72(1):51–59.
   PubMed Web of Science ®Google Scholar
• Langendonk JG, Meinders AE, Burggraaf J, et al. Influence of obesity and body fat distribution on growth hormone kinetics in humans. Am J Physiol. 1999;277(5):E824–E829.
   PubMedGoogle Scholar
• Conover CA, Lee PD, Kanaley JA, et al. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab. 1992;74(6):1355–1360.
   PubMed Web of Science ®Google Scholar
• Maccario M, Procopio M, Grottoli S, et al. Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity. Metabolism. 1996;45(3):342–346.
   PubMed Web of Science ®Google Scholar
• Saitoh H, Kamoda T, Nakahara S, et al. Serum concentrations of insulin, insulin-like growth factor(IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children. Clin Endocrinol. 1998;48(4):487–492.
   PubMed Web of Science ®Google Scholar
• Hansen TK, Fisker S, Hansen B, et al. Impact of GHBP interference on estimates of GH and GH pharmacokinetics. Clin Endocrinol. 2002;57(6):779–786.
   PubMed Web of Science ®Google Scholar
• Bidlingmaier M, Strasburger CJ. Growth hormone assays: current methodologies and their limitations. Pituitary. 2007;10(2):115–119.
   PubMed Web of Science ®Google Scholar
• Rasmussen MH, Hvidberg A, Juul A, et al. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab. 1995;80(4):1407–1415.
   PubMed Web of Science ®Google Scholar
• Argente J, Caballo N, Barrios V, et al. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J Clin Endocrinol Metab. 1997;82(7):2076–2083.
   PubMed Web of Science ®Google Scholar
• Dori EB, Avnon Ziv C, Auerbach A, et al. The inter – test variability of growth hormone stimulation tests and factors affecting this variability. Growth Horm IGF Res. 2020;55:101361.
   PubMed Web of Science ®Google Scholar
• Markkanen HM, Pekkarinen T, Hämäläinen E, et al. Gender has to be taken into account in diagnosing adult growth hormone deficiency by the GHRH plus arginine test. Growth Horm IGF Res. 2017;35:52–56.
   PubMed Web of Science ®Google Scholar
• Galazzi E, Improda N, Cerbone M, et al. Clinical benefits of sex steroids given as a priming prior to GH provocative test or as a growth-promoting therapy in peripubertal growth delays: results of a retrospective study among ENDO-ERN centres. Clin Endocrinol. 2021;94(2):219–228.
   PubMed Web of Science ®Google Scholar
• Barth JH. An evidence-base for laboratory endocrinology? Clin Biochem Rev. 2008;29(3):97–101.
   PubMedGoogle Scholar
• Reinehr T, Bechtold-Dalla Pozza S, Bettendorf M, et al. Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data. Exp Clin Endocrinol Diabetes. 2011;119(9):544–548.
   PubMed Web of Science ®Google Scholar
• Farooqi IS. Genetic and hereditary aspects of childhood obesity. Best Pract Res Clin Endocrinol Metab. 2005;19(3):359–374.
   PubMed Web of Science ®Google Scholar
• Kleinendorst L, Abawi O, van der Voorn B, et al. Identifying underlying medical causes of pediatric obesity: Results of a systematic diagnostic approach in a pediatric obesity center. PLOS One. 2020;15(5):e0232990.
   PubMed Web of Science ®Google Scholar
• Chihara K, Shimatsu A, Hizuka N, et al. A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. Eur J Endocrinol. 2007;157(1):19–27.
   PubMed Web of Science ®Google Scholar
• Popovic V. Approach to testing growth hormone (GH) secretion in obese subjects. J Clin Endocrinol Metab. 2013;98(5):1789–1796.
   PubMed Web of Science ®Google Scholar
• Henry RK. Childhood growth hormone deficiency, a diagnosis in evolution: the intersection of growth hormone history and ethics. Growth Horm IGF Res. 2020;55:101358.
   PubMed Web of Science ®Google Scholar
• Gandrud LM, Wilson DM. Is growth hormone stimulation testing in children still appropriate? Growth Horm IGF Res. 2004;14(3):185–194.
   PubMed Web of Science ®Google Scholar
• Yuen KCJ, Biller BMK, Radovick S, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract. 2019;25(11):1191–1232.
   PubMed Web of Science ®Google Scholar
• Müller TD, Nogueiras R, Andermann ML, et al. Ghrelin. Mol Metab. 2015;4(6):437–460.
   PubMed Web of Science ®Google Scholar
• EU Clinical Trials Register. Clinical trial results: open label, group comparison, dose escalation trial to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of macimorelin acetate after single oral dosing of 0.25 mg/kg, 0.5 mg/kg, and 1 mg/kg in pediatric patients with suspected growth hormone deficiency (GHD); 2021 [cited 2021 Apr 8]. Available from: https://www.clinicaltrialsregister.eu/ctr-search/trial/2018-001988-23/results
   Google Scholar
• Wit JM, Bidlingmaier M, de Bruin C, et al. A proposal for the interpretation of serum IGF-I concentration as part of laboratory screening in children with growth failure. J Clin Res Pediatr Endocrinol. 2020;12(2):130–139.
   PubMed Web of Science ®Google Scholar
• Schilbach K, Bidlingmaier M. Laboratory investigations in the diagnosis and follow-up of GH-related disorders. Arch Endocrinol Metab. 2019;63(6):618–629.
   PubMed Web of Science ®Google Scholar
• Ellis A, Seth J, Al-Sadie R, et al. An audit of the laboratory interpretation of growth hormone response to insulin-induced hypoglycaemia in the assessment of short stature in children. Ann Clin Biochem. 2003;40(Pt 3):239–243.
   PubMedGoogle Scholar
• Ross HA, Lentjes E, Menheere PP. The consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays lacks a recommendation to attempt efficacious harmonization. Clin Chem. 2011;57(10):1463; author reply 1463–1464.
   PubMed Web of Science ®Google Scholar
• Ross HA, Lentjes EW, Menheere PM, et al. Harmonization of growth hormone measurement results: the empirical approach. Clin Chim Acta. 2014;432:72–76.
   PubMed Web of Science ®Google Scholar
• Wagner IV, Paetzold C, Gausche R, et al. Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry. Eur J Endocrinol. 2014;171(3):389–397.
   PubMed Web of Science ®Google Scholar